Close

Acer Therapeutics (ACER) Plans Clinical Trial for EDSIVO Following Type B FDA Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. INFY
3. ISRG
4. TSM
5. SPY
6. JWN
7. AXP
8. SLB
9. PPG
10. PARA


Go back to Acer Therapeutics (ACER) Plans Clinical Trial for EDSIVO Following Type B FDA Meeting
(NASDAQ: ACER) Delayed: 0.90 --0 (-0%)
Previous Close $0.90    52 Week High $ 
Open $0.90    52 Week Low $ 
Day High $0.90    P/E N/A 
Day Low $0.90    EPS $ 
Volume 11,192